Patient Registries’ Impact On Clinical Trials Debated At IoM, CMS Meetings
Executive Summary
The growing use of patient registries is sparking debate on how they impact participation in randomized clinical trials, long considered the gold standard for any kind of medical data gathering
You may also be interested in...
FDA Should Track Inclusion Of Seniors In Clinical Trails More Carefully – GAO
A report by the General Accountability Office concludes that the FDA rules for drug approval fail to guarantee the safety and effectiveness of drugs for seniors
FDA Should Track Inclusion Of Seniors In Clinical Trails More Carefully – GAO
A report by the General Accountability Office concludes that the FDA rules for drug approval fail to guarantee the safety and effectiveness of drugs for seniors
Duke Studying Impact Of Clinical Trial Coverage On Enrollment For CMS
BALTIMORE - With anecdotal evidence suggesting that insurance coverage for treatment expenses associated with clinical trials may affect study participation, CMS has contracted with Duke University to conduct a more systematic evaluation of the issue